THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL

被引:175
作者
COPUR, S
AIBA, K
DRAKE, JC
ALLEGRA, CJ
CHU, E
机构
[1] NCI,NAVY MED ONCOL BRANCH,BETHESDA,MD 20889
[2] JAPANESE FDN CANC RES,CTR CANC CHEMO,TOKYO,JAPAN
关键词
THYMIDYLATE SYNTHASE; GENE AMPLIFICATION; 5-FU RESISTANCE;
D O I
10.1016/0006-2952(95)00067-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of 5-fluorouracil (5-FU)-resistant human colon H630 cancer cell lines were established by continuous exposure of cells to 5-FU. The concentration of 5-FU required to inhibit cell proliferation by 50% (IC50) in the parent colon line (H630) was 5.5 mu M. The 5-FU IC50 values for the resistant H630-R1, H630-R10, and H630-R cell lines were 11-, 29-, and 27-fold higher than that for the parent H630 cell line. Using both the radioenzymatic 5-fluoro-2'-deoxyuridine-5'-monophosphate (FdUMP) binding and catalytic assays for measurement of thymidylate synthase (TS) enzyme activity, there was significantly increased TS activity in resistant H630-R1 (13- and 23-fold), H630-R10 (37- and 40-fold), and H630-R (24- and 34-fold) lines, for binding and catalytic assays, respectively, compared with the parent H630 line. The level of TS protein, as determined by western immunoblot analysis, was increased markedly in resistant H630-R1 (23-fold), H630-R10 (33-fold), and H630-R (26-fold) cells. Northern analysis revealed elevations in TS mRNA levels in H630-R1 (18-fold), H630-R10 (39-fold), and H630-R (36-fold) cells relative to parent H630 cells. Although no major rearrangements of the TS gene were noted by Southern analysis, there was significant amplification of the TS gene in 5-FU-resistant cells, which was confirmed by DNA slot blot analysis. These studies demonstrate that continuous exposure of human colon cancer cells to 5-FU leads to TS gene amplification and overexpression of TS protein with resultant development of fluoropyrimidine resistance.
引用
收藏
页码:1419 / 1426
页数:8
相关论文
共 44 条
[31]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[32]   ADAPTATION TO 5-FLUOROURACIL OF THE HETEROGENEOUS HUMAN COLON-TUMOR CELL-LINE HT-29 RESULTS IN THE SELECTION OF CELLS COMMITTED TO DIFFERENTIATION [J].
LESUFFLEUR, T ;
KORNOWSKI, A ;
LUCCIONI, C ;
MULERIS, M ;
BARBAT, A ;
BEAUMATIN, J ;
DUSSAULX, E ;
DUTRILLAUX, B ;
ZWEIBAUM, A .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (05) :721-730
[33]   BIOCHEMICAL FACTORS AFFECTING THE TIGHTNESS OF 5-FLUORODEOXYURIDYLATATE BINDING TO HUMAN THYMIDYLATE SYNTHETASE [J].
LOCKSHIN, A ;
DANENBERG, PV .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (03) :247-257
[34]  
MAJOR PP, 1982, CANCER RES, V42, P3005
[35]  
MULKINS MA, 1982, CANCER RES, V42, P965
[36]  
PARK JG, 1987, CANCER RES, V47, P6710
[37]   FLUOROURACIL - BIOCHEMISTRY AND PHARMACOLOGY [J].
PINEDO, HM ;
PETERS, GFJ .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (10) :1653-1664
[38]  
RINALDI DA, 1994, P AN M AM SOC CLIN, V13, P159
[39]   MECHANISM OF INTERACTION OF THYMIDYLATE SYNTHETASE WITH 5-FLUORODEOXYURIDYLATE [J].
SANTI, DV ;
MCHENRY, CS ;
SOMMER, H .
BIOCHEMISTRY, 1974, 13 (03) :471-481
[40]   ELEVATED EXPRESSION OF THYMIDYLATE SYNTHASE CYCLE GENES IN CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA A2780 CELLS [J].
SCANLON, KJ ;
KASHANISABET, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) :650-653